Market revenue in 2023 | USD 213.9 million |
Market revenue in 2030 | USD 382.6 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.79% in 2023. Horizon Databook has segmented the Australia home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank Group, the country’s population aged 65 & above accounted for nearly 15.4% of the total population in 2017 and around 15.9% in 2019. Rise in geriatric population is anticipated to increase the demand for long-term and home care services, thereby fueling the market growth. Home care services are funded by the Australian government mainly under two programs Commonwealth Home Support Programmed and Home Care Packages Program.
The former program is designed to support elderly population with daily tasks at home, while the latter is designed to support complex medical needs of patients. In addition, Medicare covers home care services such as palliative care. Such supportive funding options is anticipated to boost the market growth. Moreover, Increasing Choice in Home Care (ICHC) reforms were introduced by the Australian government in February 2017. ICHC is intended to enable patients to select homecare provider as per their needs, port unspent funds to new provider, prioritize access to home care services, and offer new levels of home care packages.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Australia home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account